Volume 13; Issue 4

Main
The Lancet Oncology
Volume 13; Issue 4

The Lancet Oncology

Volume 13; Issue 4

1

Carpal tunnel syndrome and musculoskeletal symptoms in postmenopausal women with early breast cancer treated with exemestane or tamoxifen after 2–3 years of tamoxifen: a retrospective analysis of the Intergroup Exemestane Study

J Sven D Mieog, James P Morden, Judith M Bliss, R Charles Coombes, Cornelis JH van de Velde

Journal:

The Lancet Oncology

Year:

2012

Language:

english

File:

PDF, 278 KB

english, 2012

2

Genetic heterogeneity and cancer drug resistance

Nicholas C Turner, Jorge S Reis-Filho

Journal:

The Lancet Oncology

Year:

2012

Language:

english

File:

PDF, 219 KB

english, 2012

3

Tattoos, inks, and cancer

Nicolas Kluger, Virve Koljonen

Journal:

The Lancet Oncology

Year:

2012

Language:

english

File:

PDF, 111 KB

english, 2012

4

Aromatase inhibitors and musculoskeletal adverse events

Pedro ER Liedke, Paul E Goss

Journal:

The Lancet Oncology

Year:

2012

Language:

english

File:

PDF, 93 KB

english, 2012

5

Neoadjuvant anastrozole versus tamoxifen in patients receiving goserelin for premenopausal breast cancer (STAGE): a double-blind, randomised phase 3 trial

Norikazu Masuda, Yasuaki Sagara, Takayuki Kinoshita, Hiroji Iwata, Seigo Nakamura, Yasuhiro Yanagita, Reiki Nishimura, Hirotaka Iwase, Shunji Kamigaki, Hiroyuki Takei, Shinzaburo Noguchi

Journal:

The Lancet Oncology

Year:

2012

Language:

english

File:

PDF, 152 KB

english, 2012

6

Evaluation of novel radiotherapy technologies: what evidence is needed to assess their clinical and cost effectiveness, and how should we get it?

Judith van Loon, Janneke Grutters, Fergus Macbeth

Journal:

The Lancet Oncology

Year:

2012

Language:

english

File:

PDF, 179 KB

english, 2012

7

Management of elderly patients with breast cancer: updated recommendations of the International Society of Geriatric Oncology (SIOG) and European Society of Breast Cancer Specialists (EUSOMA)

Laura Biganzoli, Hans Wildiers, Catherine Oakman, Lorenza Marotti, Sibylle Loibl, Ian Kunkler, Malcolm Reed, Stefano Ciatto, Adri C Voogd, Etienne Brain, Bruno Cutuli, Catherine Terret, Margot Gosney,

Journal:

The Lancet Oncology

Year:

2012

Language:

english

File:

PDF, 124 KB

english, 2012

8

Stereotactic body radiation therapy for management of spinal metastases in patients without spinal cord compression: a phase 1–2 trial

Xin Shelley Wang, Laurence D Rhines, Almon S Shiu, James N Yang, Ugur Selek, Ibrahima Gning, Ping Liu, Pamela K Allen, Syed S Azeem, Paul D Brown, Hadley J Sharp, David C Weksberg, Charles S Cleeland,

Journal:

The Lancet Oncology

Year:

2012

Language:

english

File:

PDF, 200 KB

english, 2012

9

Inotuzumab ozogamicin, an anti-CD22–calecheamicin conjugate, for refractory and relapsed acute lymphocytic leukaemia: a phase 2 study

Hagop Kantarjian, Deborah Thomas, Jeffrey Jorgensen, Elias Jabbour, Partow Kebriaei, Michael Rytting, Sergernne York, Farhad Ravandi, Monica Kwari, Stefan Faderl, Mary Beth Rios, Jorge Cortes, Luis Fa

Journal:

The Lancet Oncology

Year:

2012

Language:

english

File:

PDF, 255 KB

english, 2012

10

Aromatase inhibitors in premenopausal breast cancer

Catherine M Kelly, Aman U Buzdar

Journal:

The Lancet Oncology

Year:

2012

Language:

english

File:

PDF, 93 KB

english, 2012

11

Association between endometriosis and risk of histological subtypes of ovarian cancer: a pooled analysis of case–control studies

Celeste Leigh Pearce, Claire Templeman, Mary Anne Rossing, Alice Lee, Aimee M Near, Penelope M Webb, Christina M Nagle, Jennifer A Doherty, Kara L Cushing-Haugen, Kristine G Wicklund, Jenny Chang-Clau

Journal:

The Lancet Oncology

Year:

2012

Language:

english

File:

PDF, 201 KB

english, 2012

12

SBRT and spinal metastasis: finding its niche

David Schiff, Jason P Sheehan

Journal:

The Lancet Oncology

Year:

2012

Language:

english

File:

PDF, 72 KB

english, 2012

13

Effect of T-cell-epitope matching at HLA-DPB1 in recipients of unrelated-donor haemopoietic-cell transplantation: a retrospective study

Katharina Fleischhauer, Bronwen E Shaw, Theodore Gooley, Mari Malkki, Peter Bardy, Jean-Denis Bignon, Valérie Dubois, Mary M Horowitz, J Alejandro Madrigal, Yasuo Morishima, Machteld Oudshoorn, Olle R

Journal:

The Lancet Oncology

Year:

2012

Language:

english

File:

PDF, 200 KB

english, 2012

14

Anti-CD22 therapy in acute lymphoblastic leukaemia

Journal:

The Lancet Oncology

Year:

2012

Language:

english

File:

PDF, 134 KB

english, 2012

15

Link between endometriosis and ovarian-cancer subtypes

Charlie Gourley

Journal:

The Lancet Oncology

Year:

2012

Language:

english

File:

PDF, 141 KB

english, 2012

16

Variation in number of general practitioner consultations before hospital referral for cancer: findings from the 2010 National Cancer Patient Experience Survey in England

Georgios Lyratzopoulos, Richard D Neal, Josephine M Barbiere, Gregory P Rubin, Gary A Abel

Journal:

The Lancet Oncology

Year:

2012

Language:

english

File:

PDF, 442 KB

english, 2012

17

Breast conserving therapy versus mastectomy for stage I–II breast cancer: 20 year follow-up of the EORTC 10801 phase 3 randomised trial

Saskia Litière, Gustavo Werutsky, Ian S Fentiman, Emiel Rutgers, Marie-Rose Christiaens, Erik Van Limbergen, Margreet HA Baaijens, Jan Bogaerts, Harry Bartelink

Journal:

The Lancet Oncology

Year:

2012

Language:

english

File:

PDF, 327 KB

english, 2012

18

Neoadjuvant bevacizumab, trastuzumab, and chemotherapy for primary inflammatory HER2-positive breast cancer (BEVERLY-2): an open-label, single-arm phase 2 study

Jean-Yves Pierga, Thierry Petit, Thierry Delozier, Jean-Marc Ferrero, Mario Campone, Joseph Gligorov, Florence Lerebours, Henri Roché, Thomas Bachelot, Emmanuelle Charafe-Jauffret, Maria Pavlyuk, Sand

Journal:

The Lancet Oncology

Year:

2012

Language:

english

File:

PDF, 188 KB

english, 2012

19

Primary care and diagnosis of cancer

Martin Gulliford

Journal:

The Lancet Oncology

Year:

2012

Language:

english

File:

PDF, 90 KB

english, 2012

20

Permissive mismatches for blood and marrow transplantation

Journal:

The Lancet Oncology

Year:

2012

Language:

english

File:

PDF, 56 KB

english, 2012

21

Long-term outcome of breast conserving therapy

Journal:

The Lancet Oncology

Year:

2012

Language:

english

File:

PDF, 143 KB

english, 2012

22

BRCA1 testing for triple-negative breast cancer

Journal:

The Lancet Oncology

Year:

2012

Language:

english

File:

PDF, 72 KB

english, 2012

23

Semuloparin for thromboprophylaxis during chemotherapy

Journal:

The Lancet Oncology

Year:

2012

Language:

english

File:

PDF, 72 KB

english, 2012

24

Inflammatory HER2-positive breast cancer

Luc Y Dirix, Peter B Vermeulen

Journal:

The Lancet Oncology

Year:

2012

Language:

english

File:

PDF, 79 KB

english, 2012

25

Absent benefit of accelerated concomitant chemoradiotherapy

Robin J Prestwich, Mehmet Sen

Journal:

The Lancet Oncology

Year:

2012

Language:

english

File:

PDF, 39 KB

english, 2012

26

Absent benefit of accelerated concomitant chemoradiotherapy – Authors' reply

Jean Bourhis, Yun Gan Tao, Pierre Blanchard, Christian Sire, Anne Aupérin

Journal:

The Lancet Oncology

Year:

2012

Language:

english

File:

PDF, 43 KB

english, 2012

27

Cancer risk and juvenile idiopathic arthritis

Olaya Astudillo

Journal:

The Lancet Oncology

Year:

2012

Language:

english

File:

PDF, 75 KB

english, 2012

28

Study shows how NSAIDs inhibit lymphatic metastasis

Journal:

The Lancet Oncology

Year:

2012

Language:

english

File:

PDF, 75 KB

english, 2012

29

Standardisation of clinical breast-density measurement

Kwan-Hoong Ng, Cheng-Har Yip, Nur Aishah Mohd Taib

Journal:

The Lancet Oncology

Year:

2012

Language:

english

File:

PDF, 190 KB

english, 2012

30

Industry group “threatens” journals to delay publications

Journal:

The Lancet Oncology

Year:

2012

Language:

english

File:

PDF, 58 KB

english, 2012

31

Unrest in Bulgarian health services

Talha Khan Burki

Journal:

The Lancet Oncology

Year:

2012

Language:

english

File:

PDF, 58 KB

english, 2012

32

Screening of symptomatic women for ovarian cancer

Christopher P Crum

Journal:

The Lancet Oncology

Year:

2012

Language:

english

File:

PDF, 36 KB

english, 2012

33

Cancer drugs not approved for Australian Government subsidies

Georgina Kenyon

Journal:

The Lancet Oncology

Year:

2012

Language:

english

File:

PDF, 70 KB

english, 2012

34

US judge strikes down graphic tobacco warnings

Journal:

The Lancet Oncology

Year:

2012

Language:

english

File:

PDF, 69 KB

english, 2012

35

Cola colourant carcinogenicity claims

Journal:

The Lancet Oncology

Year:

2012

Language:

english

File:

PDF, 47 KB

english, 2012

36

Indian government awards compulsory licence for sorafenib

Talha Khan Burki

Journal:

The Lancet Oncology

Year:

2012

Language:

english

File:

PDF, 47 KB

english, 2012

37

Second-line erlotinib for non-small-cell lung cancer

Vito Lorusso, Saverio Cinieri

Journal:

The Lancet Oncology

Year:

2012

Language:

english

File:

PDF, 70 KB

english, 2012

38

Screening of symptomatic women for ovarian cancer

Aleksandra Gentry-Maharaj, Jatinderpal Kalsi, Matthew Burnell, Ranjit Manchanda, Usha Menon

Journal:

The Lancet Oncology

Year:

2012

Language:

english

File:

PDF, 83 KB

english, 2012

39

Second-line erlotinib for non-small-cell lung cancer – Authors' reply

Journal:

The Lancet Oncology

Year:

2012

Language:

english

File:

PDF, 35 KB

english, 2012

40

Carcinogenicity of malaria and of some polyomaviruses

Véronique Bouvard, Robert A Baan, Yann Grosse, Béatrice Lauby-Secretan, Fatiha El Ghissassi, Lamia Benbrahim-Tallaa, Neela Guha, Kurt Straif

Journal:

The Lancet Oncology

Year:

2012

Language:

english

File:

PDF, 74 KB

english, 2012

41

Screening of symptomatic women for ovarian cancer – Authors' reply

Lucy Gilbert, Olga Basso

Journal:

The Lancet Oncology

Year:

2012

Language:

english

File:

PDF, 43 KB

english, 2012

42

Encouraging results for imatinib in advanced chordoma

Journal:

The Lancet Oncology

Year:

2012

Language:

english

File:

PDF, 115 KB

english, 2012

43

End of the road for red meat?

Talha Khan Burki

Journal:

The Lancet Oncology

Year:

2012

Language:

english

File:

PDF, 115 KB

english, 2012

44

Erratum

Journal:

The Lancet Oncology

Year:

2012

Language:

english

File:

PDF, 83 KB

english, 2012

45

Biology-driven medicine: tissue matters

The Lancet Oncology

Journal:

The Lancet Oncology

Year:

2012

Language:

english

File:

PDF, 57 KB

english, 2012

46

Wit

Journal:

The Lancet Oncology

Year:

2012

Language:

english

File:

PDF, 159 KB

english, 2012

47

Crowding out cancer

Mario Christodoulou

Journal:

The Lancet Oncology

Year:

2012

Language:

english

File:

PDF, 96 KB

english, 2012

48

Pink Ribbons, Inc

Talha Khan Burki

Journal:

The Lancet Oncology

Year:

2012

Language:

english

File:

PDF, 60 KB

english, 2012

49

Semper Fi: Always Faithful

Talha Khan Burki

Journal:

The Lancet Oncology

Year:

2012

Language:

english

File:

PDF, 72 KB

english, 2012

50

Voices from the front: April

David M Mastrianni

Journal:

The Lancet Oncology

Year:

2012

Language:

english

File:

PDF, 72 KB

english, 2012

51

Erratum

Journal:

The Lancet Oncology

Year:

2012

Language:

english

File:

PDF, 131 KB

english, 2012

52

Screening of symptomatic women for ovarian cancer

Alicia A Tone, David G Huntsman, Dianne M Miller

Journal:

The Lancet Oncology

Year:

2012

Language:

english

File:

PDF, 83 KB

english, 2012

To build up a library is to create a life. It’s never just a random collection of books.

— Carlos María Domínguez

Official channel

Z-Library Desktop Launcher

Tor version

Z-Library

Z-Library Since 2009 support@z-lib.do

EnglishРусскийEspañolItalianoελληνικάاللغة العربيةBahasa IndonesiaBahasa Malaysiaहिन्दीDeutschFrançaisPortuguêsУкраїнськаPolski中文繁體中文日本語Tiếng ViệtAzərbaycan DiliՀայոց լեզուภาษาไทยTürk Diliქართველიবাংলাپښتوతెలుగుاردو한국어SrpskiБългарски